These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4093819)

  • 1. The effect of age on the susceptibility of schistosomula of Schistosoma mansoni to damage by human eosinophils and neutrophils, in vitro.
    MacDonald AJ; Moqbel R; Kay AB
    J Parasitol; 1985 Dec; 71(6):838-40. PubMed ID: 4093819
    [No Abstract]   [Full Text] [Related]  

  • 2. Human eosinophil- and neutrophil-mediated killing of schistosomula of Schistosoma mansoni in vitro. I. Enhancement of complement-dependent damage by mast cell-derived mediators and formyl methionyl peptides.
    Anwar AR; McKean JR; Smithers SR; Kay AB
    J Immunol; 1980 Mar; 124(3):1122-9. PubMed ID: 7358978
    [No Abstract]   [Full Text] [Related]  

  • 3. Eosinophil-mediated killing of schistosomula of Schistosoma mansoni in vitro: synergistic effect of antibody and complement.
    McLaren DJ; Ramalho-Pinto FJ
    J Immunol; 1979 Oct; 123(4):1431-8. PubMed ID: 479590
    [No Abstract]   [Full Text] [Related]  

  • 4. Schistosoma mansoni: complement and antibody damage, mediated by human eosinophils and neutrophils, in killing schistosomula in vitro.
    McKean JR; Anwar AR; Kay AB
    Exp Parasitol; 1981 Jun; 51(3):307-17. PubMed ID: 7227485
    [No Abstract]   [Full Text] [Related]  

  • 5. Enhancement of neutrophil- and eosinophil-mediated complement-dependent killing of schistosomula of Schistosoma mansoni in vitro by leukotriene B4.
    Moqbel R; Sass-Kuhn SP; Goetzl EJ; Kay AB
    Clin Exp Immunol; 1983 Jun; 52(3):519-27. PubMed ID: 6307558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of the antibody-dependent killing of schistosomula of Schistosoma mansoni employing haptenic target antigens. II. In vitro killing of TNP-schistosomula by human eosinophils and neutrophils.
    Moser G; Sher A
    J Immunol; 1981 Mar; 126(3):1025-9. PubMed ID: 7462624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new method for the purification of human eosinophils and neutrophils, and a comparison of the ability of these cells to damage schistosomula of Schistosoma mansoni.
    Vadas MA; David JR; Butterworth A; Pisani NT; Siongok TA
    J Immunol; 1979 Apr; 122(4):1228-36. PubMed ID: 448088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions between human eosinophils and schistosomula of Schistosoma mansoni. I. Stable and irreversible antibody-dependent adherence.
    Vadas MA; Butterworth AE; Sherry B; Dessein A; Hogan M; Bout D; David JR
    J Immunol; 1980 Mar; 124(3):1441-8. PubMed ID: 6153682
    [No Abstract]   [Full Text] [Related]  

  • 9. Antibody-dependent complement-mediated killing of schistosomula in intraperitoneal diffusion chambers in mice.
    Kassis AI; Warren KS; Mahmoud AA
    J Immunol; 1979 Oct; 123(4):1659-62. PubMed ID: 479595
    [No Abstract]   [Full Text] [Related]  

  • 10. Schistosoma mansoni: acquired resistance of developing schistosomula to immune attack in vitro.
    McLaren DJ; Incani RN
    Exp Parasitol; 1982 Apr; 53(2):285-98. PubMed ID: 7060708
    [No Abstract]   [Full Text] [Related]  

  • 11. Killing of schistosomula of Schistosoma mansoni coated with antibody and/or complement by human leukocytes in vitro: requirement for complement in preferential killing by eosinophils.
    Anwar AR; Smithers SR; Kay AB
    J Immunol; 1979 Feb; 122(2):628-37. PubMed ID: 762435
    [No Abstract]   [Full Text] [Related]  

  • 12. Factors affecting the levels of antibody- and complement-dependent eosinophil-mediated damage to schistosomula of Schistosoma mansoni in vitro.
    Butterworth AE; Richardson BA
    Parasite Immunol; 1985 Mar; 7(2):119-31. PubMed ID: 4000698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Production of monoclonal anti-Schistosoma mansoni antibodies. Preliminary study of their biological activities].
    Verwaerde C; Grzych JM; Bazin H; Capron M; Capron A
    C R Seances Acad Sci D; 1979 Oct; 289(10):725-7. PubMed ID: 118823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of cell-generated hydrogen peroxide in granulocyte-mediated killing of schistosomula of Schistosoma mansoni in vitro.
    Kazura JW; Fanning MM; Blumer JL; Mahmoud AA
    J Clin Invest; 1981 Jan; 67(1):93-102. PubMed ID: 7451659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune evasion by Schistosoma mansoni: loss of susceptibility to antibody or complement-dependent eosinophil attack by schistosomula cultured in medium free of macromolecules.
    Dessein A; Samuelson JC; Butterworth AE; Hogan M; Sherry BA; Vadas MA; David JR
    Parasitology; 1981 Jun; 82(Pt 3):357-74. PubMed ID: 7243345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Killing of schistosomula of Schistosoma mansoni by normal human monocytes.
    Ellner JJ; Mahmoud AA
    J Immunol; 1979 Aug; 123(2):949-51. PubMed ID: 458160
    [No Abstract]   [Full Text] [Related]  

  • 17. Enhancement of eosinophil-mediated cytotoxicity to schistosomula of Schistosoma mansoni by autologous mononuclear cells from patients.
    Kimani G; Mkoji GM; Rashid JR; Mbugua JM; Koech D; Kamau T; Mungai B
    Parasite Immunol; 1993 May; 15(5):251-60. PubMed ID: 8332381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro schistosomulicidal effect of immune serum and eosinophils, neutrophils and lymphocytes.
    Hsü SY; Hsü HF; Isacson P; Cheng HF
    J Reticuloendothel Soc; 1977 Mar; 21(3):153-62. PubMed ID: 407358
    [No Abstract]   [Full Text] [Related]  

  • 19. Ultrastructural observations on the in vitro interaction of rat neutrophils with schistosomula of Schistosoma mansoni in the presence of antibody and/or complement.
    Incani RN; McLaren DJ
    Parasitology; 1983 Apr; 86 (Pt 2)():345-57. PubMed ID: 6856337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional studies on purified eosinophils and neutrophils from patients with Schistosoma mansoni infections.
    Vadas MA; David JR; Butterworth AE; Houba V; Sturrock RF; David L; Herson R; Siongok TA; Kimani R
    Clin Exp Immunol; 1980 Mar; 39(3):683-94. PubMed ID: 7379332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.